Pharmacokinetics and Effects of Different Formulations of Glipizide in Patients with Non-Insulin-Dependent Diabetes Mellitus
暂无分享,去创建一个
L. Groop | P. Groop | A. Melander | P. M. Hansen | O. Faber | E. Wåhlin-Boll | S. Helqvist | P. Bitzén | A. Haaber | P. Hansen
[1] L. Groop,et al. Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in Humans , 1991, Diabetes Care.
[2] O. Faber,et al. Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin. , 1976, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[3] A. Melander,et al. Interaction of Ethanol and Glipizide in Humans , 1987, Diabetes Care.
[4] D. Owens,et al. INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.
[5] L. Groop,et al. What Is the Benefit of Increasing the Sulfonylurea Dose? , 1993, Annals of Internal Medicine.
[6] O. Faber,et al. ELISA for human proinsulin. , 1986, Clinica chimica acta; international journal of clinical chemistry.
[7] A. Melander,et al. Pharmacokinetics and Effects of Glipizide in Healthy Volunteers , 1991 .